Location in VDR | Mutated VDRs | 20-Normal Compounds | 20-epi Compounds | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Calcitriol | VD 2708 | VD 2728 | MC 903 | EB 1089 | MC 1288 | VD 2668 | GS1 500 | VD 2656 | KH1 060 | CB1 260 | CB 1393 | MC1 598 | CB1 093 | HEP 187 | CB 1016 | ||
C | Y143A | + | + | + | – | – | + | + | – | – | + | – | + | – | + | – | – |
R158A | + | + | + | + | – | + | + | + | + | + | + | + | + | + | + | – | |
H3 | H229A | – | + | – | – | – | + | – | – | – | + | – | – | + | – | – | – |
D232A | – | + | – | – | – | + | – | – | – | + | – | – | + | – | – | – | |
V234A | + | + | + | + | – | + | + | + | – | + | + | + | + | + | + | + | |
S235A | + | + | + | + | + | + | + | + | + | + | – | – | – | + | + | + | |
Y236A | – | – | + | – | – | + | – | – | – | – | – | – | + | – | – | – | |
S237A | – | + | – | – | – | + | – | – | – | + | – | – | + | + | – | – | |
H5 | E269A | – | + | + | + | – | + | – | + | – | + | – | + | + | + | – | – |
S275A | + | + | + | – | + | + | – | + | – | + | – | + | + | + | + | – | |
S278A | + | + | + | + | – | + | + | + | – | + | + | + | + | + | – | – | |
H6 | D299A | + | + | + | – | – | + | – | + | – | + | – | + | + | + | – | – |
C | H305A | + | – | + | + | + | – | – | + | + | + | – | – | + | – | – | – |
(−)-Ligand treatment stabilizes the LBD by less than 20% of that of the wild-type VDR; (+)-ligand treatment stabilizes the LBD by more than 20% of that of the wild-type VDR. Locations of mutated amino acids within VDR are indicated as coil (C) or helix (H).